BG
| |
Bellevue Group AG13F | |
| Bellevue Group AG | |
| Last update 2025-05-15 | 148 Stocks (10 new) |
| Value $4.46 Bil | Turnover 4 % |
Bellevue Group AG Top Holdings of 2025-03-31
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ARGX | argenx SE | 578,874 | 342,615.3 | -2.41% | 7.680 | -0.17% | 0.950 | -5.30% | -8.20% | 34,972.3 | Biotechnology | |
IONS | Ionis Pharmaceuticals Inc | 7,853,198 | 236,931.0 | -0.20% | 5.310 | -0.01% | 4.930 | +47.04% | +19.45% | 6,646.5 | Biotechnology | |
SYK | Stryker Corp | 566,597 | 210,915.7 | +8.96% | 4.730 | +0.39% | 0.150 | +12.62% | +8.63% | 148,815.0 | Medical Devices & Instruments | |
ISRG | Intuitive Surgical Inc | 425,746 | 210,859.2 | -8.32% | 4.720 | -0.39% | 0.120 | +7.43% | -0.64% | 185,882.9 | Medical Devices & Instruments | |
ALNY | Alnylam Pharmaceuticals Inc | 768,147 | 207,415.0 | -0.28% | 4.650 | -0.01% | 0.590 | +36.65% | +36.22% | 41,793.4 | Biotechnology | |
ABT | Abbott Laboratories | 1,556,129 | 206,420.5 | -7.85% | 4.630 | -0.29% | 0.090 | -5.16% | +10.91% | 215,165.7 | Medical Devices & Instruments | |
NBIX | Neurocrine Biosciences Inc | 1,820,000 | 201,292.0 | 0% | 4.510 | 0% | 1.840 | +30.22% | -3.28% | 13,065.5 | Drug Manufacturers | |
VRTX | Vertex Pharmaceuticals Inc | 413,071 | 200,265.1 | -15.26% | 4.490 | -0.58% | 0.160 | -5.99% | +14.18% | 118,077.9 | Biotechnology | |
BSX | Boston Scientific Corp | 1,951,020 | 196,818.9 | -8.63% | 4.410 | -0.32% | 0.130 | +8.96% | +16.03% | 153,329.8 | Medical Devices & Instruments | |
RVMD | Revolution Medicines Inc | 4,374,300 | 154,675.3 | -0.29% | 3.470 | -0.01% | 2.350 | +4.19% | -12.44% | 7,134.0 | Biotechnology |
Bellevue Group AG's Historical Top Holdings Breakdowns
Bellevue Group AG's Top Stock Picks
View Full List
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ITCI Unlock Delisted | Intra-Cellular Therapies Inc | 2025-03-31 | Sold Out Sold Out | -3.92% | 81.78 ($124.62) 131.92 | $131.87 | 5.82% | Sold Out | 0 | -2,440,240 | |
AKRO | Akero Therapeutics Inc | 2025-03-31 | New Buy New Buy | +1.13% | 21.87 ($42.39) 57.56 | $52.08 | 22.86% | New holding | 1,250,666 | 1,250,666 | |
ARVN | Arvinas Inc | 2025-03-31 | Sold Out Sold Out | -0.88% | 7.02 ($15.67) 20.5 | $7.35 | -53.10% | Sold Out | 0 | -2,389,600 | |
VRTX | Vertex Pharmaceuticals Inc | 2025-03-31 | Reduce Reduce | -0.58% | 402.49 ($466) 513.76 | $459.81 | -1.33% | Reduce -15.26% | 413,071 | -74,363 | |
TNDM | Tandem Diabetes Care Inc | 2025-03-31 | Sold Out Sold Out | -0.54% | 17.89 ($29.26) 37.53 | $14.77 | -49.52% | Sold Out | 0 | -782,456 | |
SAGE | Sage Therapeutics Inc | 2025-03-31 | Sold Out Sold Out | -0.47% | 5.55 ($7.32) 8.66 | $9.11 | 24.45% | Sold Out | 0 | -4,460,693 | |
VRNA | Verona Pharma PLC | 2025-03-31 | Reduce Reduce | -0.46% | 44.81 ($59.82) 69.63 | $104.90 | 75.36% | Reduce -89.23% | 61,261 | -507,694 | |
ABBV | AbbVie Inc | 2025-03-31 | Add Add | +0.42% | 169.2 ($194.4) 216.66 | $189.26 | -2.64% | Add 198.81% | 135,240 | 89,981 | |
ISRG | Intuitive Surgical Inc | 2025-03-31 | Reduce Reduce | -0.39% | 476.78 ($553.02) 610.45 | $518.62 | -6.22% | Reduce -8.32% | 425,746 | -38,631 | |
SYK | Stryker Corp | 2025-03-31 | Add Add | +0.39% | 355.18 ($380.56) 399.9 | $389.40 | 2.32% | Add 8.96% | 566,597 | 46,571 |
Bellevue Group AG Total Holding History ($B)
Bellevue Group AG's Asset Allocation
Bellevue Group AG Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
Bellevue Group AG's Hypothetical Growth since 2025-03-31
Bellevue Group AG's Yearly Returns
| Year | Portfolio % | % | Excess Gain % |
|---|
Bellevue Group AG's Holdings Heat Map
Size field:
Bellevue Group AG's Holdings Bubble Chart
Bellevue Group AG News
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers